Analyst Ratings for Entasis Therapeutics (ETTX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.3 / 10
Percentile Rank: 43%
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2022 | Cantor Fitzgerald | Louise Chen | Downgrade | Neutral (Overweight) |
2.00 (5.00) |
1.91 (2.19) |
14.66% | Details |
| 3/16/2022 | Alliance Global Partners | James Molloy | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.86 (2.19) |
17.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
